RxDoctor Payments Data

Rodger Elofson

Adolescent Medicine · Baton Rouge, LANPI 1700997103

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Neos Therapeutics, LP at 28.5% of the total. Reporting peaked in 2019 at $464 and has fallen 95.9% since, to $19 in 2025.

$949in general payments, 2019–2025

Across 65 payments — averaging $14.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neos Therapeutics, LP$271
  • Tris Pharma Inc$254
  • Takeda Pharmaceuticals U.S.A., Inc.$126
  • Merck$74
  • Ironshore Pharmaceuticals Inc.$41
  • Pfizer$30
  • plus $153 from 8 others
$105,242in research payments, 2019–2025

Across 51 payments — averaging $2063.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$97K
  • Merck$8K

What the payments were for

  • Food & beverage$949100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$949 in reported general payments places this provider in the 75th percentile of 34 adolescent medicine providers in Louisiana.

See all adolescent medicine providers in Louisiana

Other adolescent medicine in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →